Clinical Trial

The Safety and Pharmacokinetics of ASKC200 in Osteoarthritic Knee Pain

Study acronym: ASKC200
Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated September 27, 2024 (before its estimated April 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a multi-center, randomized, double-blind clinical trial to evaluate the safety, tolerability, pharmacokinetics, and efficacy of ASKC200 in subjects with OA of the knees and determine the phase II recommended dose. Assigned doses will be applied for 60 minutes on each of four consecutive days.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-24.
Trial Details
NCT Number NCT06614608
Lead Sponsor Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Conditions Osteoarthritis, Knee, Pain
Enrollment 24 participants
Start Date 2024-10
Primary Completion 2025-04 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2024-09-27